DST-TDB Supports Bioneemtec for Green Pharma Manufacturing Commercialisation
The Department of Science and Technology (DST) is supporting Bioneemtec India in the commercialisation of green chemistry-based pharmaceutical manufacturing technologies, aiming to strengthen indigenous API production and advance next-generation therapeutics.
Pharmaceutical Commercialisation | 06/06/2026 | By News Bureau | 134
Marksans Pharma Acquires Netherlands-Based QliniQ B.V. to Strengthen Europe Business
Marksans Pharma is set to acquire Netherlands-based QliniQ BV, a strategic move that expands its footprint in regulated European markets and strengthens its forward-integration strategy through direct market-access capabilities across the European Union (EU).
Pharmaceutical Commercialisation | 01/06/2026 | By News Bureau | 135
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy